Market Forecast by Countries (Germany, United Kingdom, France, Italy, Russia, Spain, Rest of Europe), By Study Design (Interventional, Expanded Access, Observational), By Indication (Cardiovascular, Oncology, Others) And Competitive Landscape
Product Code: ETC078222 | Publication Date: Aug 2021 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
Europe Virtual Clinical Trials Market is expected to register growth proliferation in the coming years. In Europe, the increasing occurrences of people suffering from chronic diseases, infectious diseases and neurological diseases coupled with rising geriatric population are some of the factors propelling the growth of market. Advancement in technology in the healthcare industry are further anticipate to fuel the overall growth of the market. The growth of the market is substantially driven recently owing to the Covid-19 outbreak across the globe. Growing clinical trials to find reliable and effective solutions to cure or decline and prevent the spread of neurological disorders and age-related diseases are components that will boost the growth of the virtual clinical trials market during the forecast period. Virtual trial technology aims to alleviate this burden to some degree, with the aim of boosting clinical trial enrolment, and reducing drop-out rates. A virtual technique permits people to participate in the trial from the comfort of their homes which ensures that studies can be continued even when site visits are not feasible. Furthermore, it is a unique method of gathering secure and effective data from participants of clinical researches. The Biggest impact of Covid19 in European region is the lack of site staff availability to do anything trial-related as many are being re-deployed to Emergency Rooms. A number of EU sites, such as Poland, France, Italy, and UK, have suspended trial activities with the exception of treating ongoing patients to prevent missed treatment.
According the 6Wresearch, The Europe Virtual Clinical Trials Market is likely to witness significant growth during 2021-2027.The Virtual Clinical Research landscape in the UK is rapidly evolving to become more patient-centric in how we identify, engage, and enrol participants. Europe witnessed a significant growth in terms of CAGR in the global virtual trials market over the past few years owing to rising R&D in the healthcare sector and for being one of the most adversely affected regions by Covid-19.
The Europe Virtual Clinical trial market is segmented on the basis of Study type, By indication, and by Regions. Based on study type the market is bifurcated into Interventional, observational and expanded access and others. Based on Indication the market bifurcated into Oncology, cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and other indications.The existence of the leading players and benefits environment for carrying out clinical trials is another element anticipated to push the growth of the clinical trial in the regions. The Key players profiled Virtual clinical trial market are IQVIA holdings, ICON PLC, Laboratory corporation of America Holdings (Covance, Inc.), Dassault systems, Oracle Corporation, Parexel International Corporation health Sciences, Medpace Holdings, Medable, Clinical Ink, Inc. An increasing number of biotechnology firms are looking at the Europe region for the Covid19 trials to take advantage of the large patient pool and fast track procedures.
The Europe Virtual Clinical trial market report thoroughly covers the market by study, indications and key countries including Germany, United Kingdom, France, Russia, Italy, Spain and rest of Europe. The Europe Virtual Clinical Trial market outlook report provides an unbiased and detailed analysis of the on-going Europe market trends, high growth areas and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Markets Covered
The Market Report covers the following segment:
Other Key Reports Available:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Virtual Clinical Trials Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Virtual Clinical Trials Market Revenues & Volume, 2020 & 2027F |
3.3 Europe Virtual Clinical Trials Market - Industry Life Cycle |
3.4 Europe Virtual Clinical Trials Market - Porter's Five Forces |
3.5 Europe Virtual Clinical Trials Market Revenues & Volume Share, By Countries, 2020 & 2027F |
3.6 Europe Virtual Clinical Trials Market Revenues & Volume Share, By Study Design, 2020 & 2027F |
3.7 Europe Virtual Clinical Trials Market Revenues & Volume Share, By Indication, 2020 & 2027F |
4 Europe Virtual Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Virtual Clinical Trials Market Trends |
6 Europe Virtual Clinical Trials Market, 2017 - 2027 |
6.1 Europe Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
6.2 Europe Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
7 Germany Virtual Clinical Trials Market, 2017 - 2027 |
7.1 Germany Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
7.2 Germany Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
8 United Kingdom Virtual Clinical Trials Market, 2017 - 2027 |
8.1 United Kingdom Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
8.2 United Kingdom Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
9 France Virtual Clinical Trials Market, 2017 - 2027 |
9.1 France Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
9.2 France Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
10 Italy Virtual Clinical Trials Market, 2017 - 2027 |
10.1 Italy Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
10.2 Italy Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
11 Russia Virtual Clinical Trials Market, 2017 - 2027 |
11.1 Russia Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
11.2 Russia Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
12 Spain Virtual Clinical Trials Market, 2017 - 2027 |
12.1 Spain Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
12.2 Spain Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
13 Rest of Europe Virtual Clinical Trials Market, 2017 - 2027 |
13.1 Rest of Europe Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
13.2 Rest of Europe Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
14 Europe Virtual Clinical Trials Market Key Performance Indicators |
15 Europe Virtual Clinical Trials Market - Opportunity Assessment |
15.1 Europe Virtual Clinical Trials Market Opportunity Assessment, By Countries, 2020 & 2027F |
15.2 Europe Virtual Clinical Trials Market Opportunity Assessment, By Study Design, 2020 & 2027F |
15.3 Europe Virtual Clinical Trials Market Opportunity Assessment, By Indication, 2020 & 2027F |
16 Europe Virtual Clinical Trials Market - Competitive Landscape |
16.1 Europe Virtual Clinical Trials Market Revenue Share, By Companies, 2020 |
16.2 Europe Virtual Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Company Profiles |
18 Recommendations |
19 Disclaimer |